Vor Biopharma Inc. (VOR) Financials

VOR Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 198.1 million 47.4 million
2023-09-30 223.0 million 48.2 million
2023-06-30 251.0 million 46.5 million
2023-03-31 277.5 million 47.3 million

VOR Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -24.1 million 1.9 million
2023-09-30 -28.4 million 3.2 million
2023-06-30 -24.5 million 4.2 million
2023-03-31 -24.4 million 4.1 million

VOR Net Income

No data available :(

VOR Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 - - 35.7 million
2023-09-30 160.1 million - 36.6 million
2023-06-30 186.9 million - 37.5 million
2023-03-31 210.2 million - 38.5 million

VOR Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 67.9 million
2023-09-30 67.6 million
2023-06-30 67.0 million
2023-03-31 66.3 million

VOR Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 111000 20.9 million 7.2 million -
2023-09-30 465000 27.6 million 7.7 million -
2023-06-30 399000 23.9 million 8.3 million -
2023-03-31 94000 21.9 million 8.5 million -

VOR Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 - -
2023-09-30 - 2.1 million
2023-06-30 - 1.2 million
2023-03-31 - 2.8 million

VOR

Price: $1.69

52 week price:
1.62
5.70

Earnings Per Share: -1.75 USD

P/E Ratio: -1.17

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 63919

Market Capitalization: 129.6 million

Links: